Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

Share Price is delayed by 15 minutes
Get Live Data
214.50    -8.00 (-3.60%)
Bid:
211.00
Ask:
218.00
Spread: 7.00 (3.318%)
Market Cap: £146.53m
HUW Live PriceLast checked at - London Stock Exchange

Intraday Helios Underw Share Chart

Quarterly Syndicate Mid-point Forecasts

18 Nov 2019 07:00

RNS Number : 6521T
Helios Underwriting Plc
18 November 2019
Β 

Β 

Helios Underwriting plc

("Helios" or the "Company")

Β 

Quarterly Syndicate Mid-point Forecasts

Β 

Helios, the unique investment vehicle which acquires and consolidates private underwriting capacity at Lloyd's, announces the current mid-point forecasts in respect of its portfolio of syndicate capacity for the 2017 and 2018 years of account based on 3rd quarter 2019 estimates.

Β 

Β 

Β 

Year of Account

Β 

2017

2018

2019

Β 

Β£m

Β£m

Β£m

Capacity - Position as at 15th November 2019

Β 

Β 

Retained

30.7

20.7

16.7

Reinsured

25.4

38.3

39.0

Β 

56.1

59.0

55.7

Β 

Β 

Β 

Β 

Mid-point forecast at 30th June 2019

(7.40)%

(3.56)%

Β 

Current mid-point forecast

(6.51)%

(3.39)%

Β 

Β 

Β 

Β 

Β 

Lloyd's Market Average

(9.01)%

(5.44)%

Β 

Helios out performance

2.50%

2.05%

Β 

Β 

Notes

Β 

1) The table shows the capacity as at 15th November 2019 splitting the capacity retained by Helios and the capacity that is ceded to quota share reinsurers.

2) The midpoint forecasts for 2017 and 2018 years of account as of 3rd quarter 2019 have been aggregated at syndicate level from estimates supplied by Managing Agents.

3) The change in the midpoint estimates on the retained capacity over the year will be recognised in the Helios income statement in the year to 31st December 2019.

Β 

Nigel Hanbury, Chief Executive, commented:

Β 

"As the only quoted consolidator of private capital at Lloyd's, Helios offers a unique opportunity for growth and returns from exposure to the Lloyd's market through targeted acquisitions of capacity on the better quality syndicates. We are delighted with the improvement in the results for both underwriting years and in the increased outperformance of the portfolio against the Lloyds' market"

Β 

For further information, please contact:

Helios Underwriting plc

Β 

Nigel Hanbury - Chief Executive

07787530 404 / nigel.hanbury@huwplc.com

Arthur Manners - Chief Financial Officer

07754 965 917

Β 

Β 

Shore Capital

Β 

Robert Finlay/David Coaten (Corporate Advisory)

020 7408 4050

Henry Willcocks (Corporate Broking)

Β 

Β 

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market writing approximately Β£56m of capacity for the 2019 account. The portfolio provides a good spread of business being concentrated in property insurance and reinsurance. For further information please visit www.huwplc.com.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
MSCGGGUCGUPBGMA
Date   Source Headline
1st Jun 20267:00 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
27th May 20267:00 amRNSNotice of AGM
26th May 20267:00 amRNSTransaction in Own Shares
21st May 20267:00 amRNSFinal Results for the year ended 31 December 2025
18th May 20267:00 amRNSTransaction in Own Shares
14th May 20267:00 amRNSTR-1 announcement
11th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSTotal Voting Rights
27th Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSTR-1: Acquisition of Voting Rights
21st Apr 20267:00 amRNSChange of Nominated Adviser
20th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20265:17 pmRNSHolding(s) in Company
10th Apr 20267:00 amRNSDirector/PDMR Shareholding
9th Apr 20267:00 amRNSQuarterly Syndicate Mid-point Forecast update
20th Jan 20267:00 amRNS2026 YOA Portfolio Update
9th Jan 20267:00 amRNSAppointment of Chief Underwriting Officer
4th Dec 20255:42 pmRNSGrant of LTIP Awards
2nd Dec 20257:00 amRNSNet Asset Value(s)
13th Nov 20251:32 pmRNSDirector/PDMR Shareholding
13th Nov 20251:30 pmRNSDirector/PDMR Shareholding
7th Nov 202510:10 amRNSHolding(s) in Company
6th Nov 20251:51 pmRNSDirector/PDMR Shareholding
5th Nov 20255:48 pmRNSTR1 - Change in breakdown of voting rights
30th Oct 20257:00 amRNSResult of Tender Offer
24th Oct 202512:20 pmRNSResults of General Meeting
21st Oct 20257:01 amRNSDirector Appointments
21st Oct 20257:00 amRNSCapital Markets Day
29th Sep 20257:01 amRNSProposed Tender Offer and Notice of GM
29th Sep 20257:00 amRNSHalf Year Results
19th Sep 20257:00 amRNSAppointment of Chief Executive Officer
1st Sep 20253:37 pmRNSDirector/PDMR Shareholding
29th Aug 202512:52 pmRNSPDMR Dealing
28th Aug 20252:16 pmRNSDirector/PDMR Shareholding
26th Aug 20257:00 amRNSQuarterly Syndicate Mid-point Forecasts
1st Aug 20257:00 amRNSTotal Voting Rights
31st Jul 202512:12 pmRNSTR-1: Notification of major holdings
18th Jul 20257:00 amRNSResults of Scrip Dividend Election
9th Jul 20259:45 amRNSResults of Scrip Dividend Election
30th Jun 20255:40 pmRNSAppointment of Executive Director
30th Jun 202512:28 pmRNSResult of AGM
30th Jun 20257:00 amRNSChange of Nominated Adviser
20th Jun 20259:32 amRNSScrip Dividend Reference Price
9th Jun 20251:15 pmRNSLTIP Exercise and Total Voting Rights Update
9th Jun 20251:15 pmRNSGrant of LTIP Awards
2nd Jun 20257:00 amRNSPosting of Annual Report and Notice of AGM
2nd Jun 20257:00 amRNSFinal results for the year ended 31 December 2024
29th May 20257:06 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.